{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:24:34Z","timestamp":1764689074389},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Syst"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10916-015-0361-9","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T06:06:27Z","timestamp":1446530787000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Decision Tree Based Classifier to Analyze Human Ovarian Cancer cDNA Microarray Datasets"],"prefix":"10.1007","volume":"40","author":[{"given":"Meng-Hsiun","family":"Tsai","sequence":"first","affiliation":[]},{"given":"Hsin-Chieh","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Guan-Wei","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Yi-Chen","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Sheng-Hsiung","family":"Chiu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"issue":"3","key":"361_CR1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres, M., and Barbacid, M., Milestones in cell division: to cycle or not to cycle: A critical decision in cancer. Nat. Rev. Cancer 1(3):222\u2013231, 2001.","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"361_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S., and Mak, T. W., Regulation of cancer cell metabolism. Nat. Rev. Cancer 11(2):85\u201395, 2011.","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"361_CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1373\/clinchem.2013.211490","volume":"60","author":"QH Meng","year":"2014","unstructured":"Meng, Q. H., et al., Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clin. Chem. 60(1):222\u2013232, 2014.","journal-title":"Clin. Chem."},{"issue":"2","key":"361_CR4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1078-0432.CCR-11-1282","volume":"18","author":"R Lazova","year":"2012","unstructured":"Lazova, R., et al., Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin. Cancer Res. 18(2):370\u2013379, 2012.","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"361_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajog.2008.04.009","volume":"199","author":"V Nossov","year":"2008","unstructured":"Nossov, V., et al., The early detection of ovarian cancer: From traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol 199(3):215\u2013223, 2008.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"361_CR6","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1172\/JCI65859","volume":"123","author":"C-L Chen","year":"2013","unstructured":"Chen, C.-L., et al., Reciprocal regulation by TLR4 and TGF-\u03b2 in tumor-initiating stem-like cells. J. Clin. Invest. 123(7):2832, 2013.","journal-title":"J. Clin. Invest."},{"key":"361_CR7","volume-title":"Classification and regression trees","author":"L Breiman","year":"1993","unstructured":"Breiman, L., et al., Classification and regression trees. Chapman and Hall, New York, 1993."},{"key":"361_CR8","volume-title":"Data mining technique: For marketing, sales and customer support","author":"JA Michael","year":"1997","unstructured":"Michael, J. A., and Gordon, S. L., Data mining technique: For marketing, sales and customer support. Wiley, New York, 1997."},{"issue":"2","key":"361_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pros.10205","volume":"55","author":"C Chen","year":"2003","unstructured":"Chen, C., et al., KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55(2):81\u201388, 2003.","journal-title":"Prostate"},{"key":"361_CR10","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/sj.onc.1205817","volume":"21","author":"C Chen","year":"2002","unstructured":"Chen, C., et al., A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21:6567\u20136572, 2002.","journal-title":"Oncogene"},{"key":"361_CR11","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M311532200","volume":"279","author":"NW Bateman","year":"2004","unstructured":"Bateman, N. W., et al., Intestinal tumor progression is associated with altered function of KLF5. J. Biol. Chem. 279:12093\u201312101, 2004.","journal-title":"J. Biol. Chem."},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1074\/jbc.C000870200","volume":"276","author":"R Sun","year":"2001","unstructured":"Sun, R., et al., Intestinal-enriched Kr\u00fcppel-like factor (Kr\u00fcppel-like Factor 5) is a positive regulator of cellular proliferation. J. Biol. Chem. 276:6897\u20136900, 2001.","journal-title":"J. Biol. Chem."},{"key":"361_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2004.11.005","volume":"1","author":"Y Oishi","year":"2005","unstructured":"Oishi, Y., et al., Kr\u00fcppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1:27\u201339, 2005.","journal-title":"Cell Metab."},{"key":"361_CR14","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1038\/sj.onc.1207397","volume":"23","author":"MO Nandan","year":"2004","unstructured":"Nandan, M. O., et al., Kr\u00fcppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 23:3404\u20133413, 2004.","journal-title":"Oncogene"},{"issue":"2","key":"361_CR15","first-page":"559","volume":"27","author":"A Beltran","year":"2012","unstructured":"Beltran, A., et al., Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma. J. Biol. Regul. Homeost. Agents 27(2):559\u2013567, 2012.","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"2","key":"361_CR16","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","volume":"4","author":"R Schmitz","year":"2014","unstructured":"Schmitz, R., et al., Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med 4(2):a014282, 2014.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"361_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcmd.2014.11.005","volume":"54","author":"S Guan","year":"2015","unstructured":"Guan, S., et al., Characterization of single amino acid substitutions in the \u03b22 integrin subunit of patients with leukocyte adhesion deficiency (LAD)-1. Blood Cell Mol. Dis. 54(2):177\u2013182, 2015.","journal-title":"Blood Cell Mol. Dis."},{"key":"361_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-11-36","volume":"11","author":"DA Tumbarello","year":"2012","unstructured":"Tumbarello, D. A., et al., Beta3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells. Mol. Cancer 11:36, 2012.","journal-title":"Mol. Cancer"},{"issue":"23","key":"361_CR19","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/sj.onc.1203604","volume":"19","author":"M Saitou","year":"2000","unstructured":"Saitou, M., et al., Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene 19(23):2796\u20132802, 2000.","journal-title":"Oncogene"},{"issue":"8","key":"361_CR20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.bjc.6602138","volume":"91","author":"XY Dong","year":"2004","unstructured":"Dong, X. Y., et al., Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients. Br. J. Cancer 91(8):1566\u20131570, 2004.","journal-title":"Br. J. Cancer"},{"issue":"3","key":"361_CR21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jmb.2008.07.016","volume":"382","author":"U Karvonen","year":"2008","unstructured":"Karvonen, U., et al., ZNF451 is a novel PML body-and SUMO-associated transcriptional coregulator. J. Mol. Biol. 382(3):585\u2013600, 2008.","journal-title":"J. Mol. Biol."},{"issue":"7","key":"361_CR22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ijc.23267","volume":"122","author":"A Tripathi","year":"2008","unstructured":"Tripathi, A., et al., Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int. J. Cancer 122(7):1557\u20131566, 2008.","journal-title":"Int. J. Cancer"},{"issue":"3","key":"361_CR23","first-page":"579","volume":"33","author":"B Craig","year":"2008","unstructured":"Craig, B., et al., The expression ratio of Map7\/B2M is prognostic for survival in patients with stage II colon cancer. Int. J. Oncol. 33(3):579\u2013584, 2008.","journal-title":"Int. J. Oncol."},{"issue":"10","key":"361_CR24","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.7150\/thno.9727","volume":"4","author":"Tala","year":"2014","unstructured":"Tala, et al., Microtubule-associated protein Mdp3 promotes breast cancer growth and metastasis. Theranostics 4(10):1052\u20131061, 2014.","journal-title":"Theranostics"},{"issue":"3","key":"361_CR25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00280-013-2246-2","volume":"72","author":"MD Beatrice","year":"2013","unstructured":"Beatrice, M. D., et al., The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer. Cancer Chemother. Pharmacol. 72(3):669\u2013682, 2013.","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"361_CR26","first-page":"255","volume":"8","author":"AL Wong","year":"2011","unstructured":"Wong, A. L., et al., Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients. Cancer Genomics Proteomics 8(5):255\u2013259, 2011.","journal-title":"Cancer Genomics Proteomics"},{"key":"361_CR27","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/en.2010-1095","volume":"152","author":"HB Boldt","year":"2011","unstructured":"Boldt, H. B., and Conover, C. A., Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. Endocrinology 152:1470\u20138, 2011.","journal-title":"Endocrinology"},{"issue":"4","key":"361_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cpr.12043","volume":"46","author":"Z Dong","year":"2013","unstructured":"Dong, Z., et al., KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression. Cell Prolif. 46(4):425\u2013435, 2013.","journal-title":"Cell Prolif."},{"issue":"8","key":"361_CR29","volume":"10","author":"EK Crane","year":"2015","unstructured":"Crane, E. K., et al., Nutlin-3a: A potential therapeutic opportunity for TP53 wild-type ovarian carcinomas. PLoS One 10(8), e0135101, 2015.","journal-title":"PLoS One"},{"issue":"4","key":"361_CR30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/1535-7163.MCT-14-0880","volume":"14","author":"MA Becker","year":"2015","unstructured":"Becker, M. A., et al., A novel neutralizing antibody targeting pregnancy-associated plasma protein-A inhibits ovarian cancer growth and Ascites accumulation in patient mouse Tumorgrafts. Mol. Cancer Ther. 14(4):973\u2013981, 2015.","journal-title":"Mol. Cancer Ther."},{"key":"361_CR31","unstructured":"Tsai, M. H. et al. (2014) A bio-inspired computing model for Ovarian Carcinoma classification and oncogene detection. Bioinformatics btu782."}],"container-title":["Journal of Medical Systems"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-015-0361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10916-015-0361-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-015-0361-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:50:59Z","timestamp":1559451059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10916-015-0361-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s10916-015-0361-9","relation":{},"ISSN":["0148-5598","1573-689X"],"issn-type":[{"value":"0148-5598","type":"print"},{"value":"1573-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]},"article-number":"21"}}